Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $321.11 Analyst target: $362.54 Upside: 12.90%
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company is headquartered in Alameda, California.
See the full interactive analysis & chart →Informational only — not investment advice.